Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (18) Valtrex (valacyclovir HCl), GlaxoSmithKline,
...Newly Approved Drug Therapies (18) Valtrex (valacyclovir HCl), GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Valtrex (valacyclovir HCl) Company: GlaxoSmithKline Approval Status: Approved December 1995 Treatment Area: herpes simplex General Information Valtrex ...
View Page

2.  Study Posting (2246) Trial #136016, Brain Cancer, Duarte, CA
...Trial #136016, Brain Cancer, Duarte, CA Trial Information A Phase IIa Study of ADV-TK + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Malignant Gliomas You have been asked ...
...an experimental gene transfer treatment explained further in section II) is given in combination with valacyclovir and radiation therapy. The researchers will also look at the type of side effects the ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (225), Shingles
...to receive 1, 2 or 3 grams of once-daily valomaciclovir or standard of care (valacyclovir: 1 gram, three times per day). The primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash. The two highest doses ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (81), Herpes Zoster Infections
...to receive 1, 2 or 3 grams of once-daily valomaciclovir or standard of care (valacyclovir: 1 gram, three times per day). The primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash. The two highest doses ...
View Page

5.  CenterWatch: Clinical Trials in Category (28) Brain Cancer
...California • Texas California Duarte : City of Hope New! A Phase IIa Study of ADV-TK + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Malignant Gliomas Duarte : City of Hope ...
View Page

6.  Study Posting (2246) Trial #129806, Pancreatic Cancer, Duarte, CA
...the gene susceptible to (be killed by) a medicine normally used to treat herpes infections (valacyclovir). This research approach is being evaluated in combination with standard treatments for pancreatic cancer, such ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (173), Genital Herpes
...future. January 12, 2004 GlaxoSmithKline reported positive results from a post-marketing trial for Valtrex (valacyclovir) , an approved genital herpes agent, testing the indication of reducing viral transmission. Results showed that ...
View Page

8.  Study Posting (4519) Trial #124464, Cytomegalovirus Infections, Pittsburgh, PA
...4 days) prior to pharmacokinetic assessments. Exclusion Criteria: • history of any adverse reaction to acyclovir, valacyclovir, ganciclovir or valganciclovir; • evidence of graft rejection; • patient has received anti-CMV prophylaxis with a ...
View Page

9.  Study Posting (4519) Trial #124246, Cytomegalovirus Infections, Cleveland, OH
...4 days) prior to pharmacokinetic assessments. Exclusion Criteria: • history of any adverse reaction to acyclovir, valacyclovir, ganciclovir or valganciclovir; • evidence of graft rejection; • patient has received anti-CMV prophylaxis with a ...
View Page

10.  Study Posting (4519) Trial #123579, Cytomegalovirus Infections, Durham, NC
...4 days) prior to pharmacokinetic assessments. Exclusion Criteria: • history of any adverse reaction to acyclovir, valacyclovir, ganciclovir or valganciclovir; • evidence of graft rejection; • patient has received anti-CMV prophylaxis with a ...
View Page

11.  Study Posting (4519) Trial #123966, Cytomegalovirus Infections, Los Angeles, CA
...4 days) prior to pharmacokinetic assessments. Exclusion Criteria: • history of any adverse reaction to acyclovir, valacyclovir, ganciclovir or valganciclovir; • evidence of graft rejection; • patient has received anti-CMV prophylaxis with a ...
View Page

12.  CenterWatch: List of Newly Approved Drug Thearapies
...December 1995 Invirase (saquinavir) ; Roche; Treatment for HIV/AIDS, Approved on December 7, 1995 Valtrex (valacyclovir HCl) ; GlaxoSmithKline; Treatment for recurrent genital herpes, Approved December 1995 Western blot confirmatory device ; Epitope ...
View Page

13.  CenterWatch Clinical Research Profile (2246) Trial #1369, City of Hope, Duarte, CA
...Hormone-Refractory Prostate Cancer, Previously Treated with Chemotherapy • A Phase IIa Study of ADV-TK + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Malignant Gliomas • A Pilot Study of ...
View Page

14.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...December 1995 Invirase (saquinavir) ; Roche; Treatment for HIV/AIDS, Approved on December 7, 1995 Valtrex (valacyclovir HCl) ; GlaxoSmithKline; Treatment for recurrent genital herpes, Approved December 1995 Western blot confirmatory device ; Epitope ...
View Page